Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Jun;195(6):570-572.
doi: 10.1007/s00066-019-01449-2.

[FOLFIRINOX after resection of pancreatic cancer sets new standards-systemic therapy providing an impulse for local treatment in resectable pancreatic cancer]

[Article in German]
Sabine Semrau  1 , Dorota Lubgan  2
Affiliations
Comment

[FOLFIRINOX after resection of pancreatic cancer sets new standards-systemic therapy providing an impulse for local treatment in resectable pancreatic cancer]

[Article in German]
Sabine Semrau et al. Strahlenther Onkol. 2019 Jun.
No abstract available

PubMed Disclaimer

Comment on

  • FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
    Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul JL, Choné L, Francois E, Artru P, Biagi JJ, Lecomte T, Assenat E, Faroux R, Ychou M, Volet J, Sauvanet A, Breysacher G, Di Fiore F, Cripps C, Kavan P, Texereau P, Bouhier-Leporrier K, Khemissa-Akouz F, Legoux JL, Juzyna B, Gourgou S, O'Callaghan CJ, Jouffroy-Zeller C, Rat P, Malka D, Castan F, Bachet JB; Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group. Conroy T, et al. N Engl J Med. 2018 Dec 20;379(25):2395-2406. doi: 10.1056/NEJMoa1809775. N Engl J Med. 2018. PMID: 30575490 Clinical Trial.

References

    1. JAMA. 2013 Oct 9;310(14):1473-81 - PubMed
    1. Eur J Surg Oncol. 2009 Jun;35(6):600-4 - PubMed
    1. Strahlenther Onkol. 2015 Jan;191(1):7-16 - PubMed
    1. Strahlenther Onkol. 2018 Mar;194(3):185-195 - PubMed
    1. World J Surg Oncol. 2017 Oct 10;15(1):183 - PubMed

LinkOut - more resources